Scleral Allografting and Amniotic Membrane Transplantation With Fibrin Glue in the Management of Scleromalacia.
10.3341/jkos.2010.51.4.485
- Author:
Byeong Hee LEE
1
;
Hong Jae MUN
;
Young Jeung PARK
;
Kyoo Won LEE
Author Information
1. Cheil Eye Hospital, Daegu, Korea. eyepark9@dreamwiz.com
- Publication Type:Original Article
- Keywords:
AMT;
Fibrin glue;
Scleral graft;
Scleromalacia
- MeSH:
Amnion;
Eye;
Fibrin;
Fibrin Tissue Adhesive;
Follow-Up Studies;
Humans;
Safety;
Sclera;
Transplantation, Homologous;
Transplants
- From:Journal of the Korean Ophthalmological Society
2010;51(4):485-491
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To examine the effects, complications, and safeties of sclera allograft and amniotic membrane transplantation with fibrin glue as surgical treatment methods for scleromalacia. METHODS: The study included 14 eyes of 14 scleromalacia patients who needed surgical treatment. Among them, seven eyes of seven patients whose scleral defect was small (<6 mm) were operated on using only fibrin glue and no suturing, while seven eyes of seven patients whose defect was large (>6 mm) were operated on using fibrin glue and minimum suturing. Amniotic membrane transplantation was performed at the site of the conjunctival defect. RESULTS: In all of the cases, the results of grafting were successful throughout the follow-up period, which was 14.6+/-4.4 months, on average (ranging from 12 to 27 months). No particular complication was observed during the follow-up period after using fibrin glue. CONCLUSIONS: For scleromalacia patients, sclera allograft and amniotic membrane transplantation were performed using fibrin glue. The grafted sclera survived successfully, allowing this treatment modality to be considered an effective and safe option without complications.
